Le Lézard
Classified in: Business

CI Investments becomes first company to surpass $2 billion in liquid alternatives

TORONTO, July 16, 2020 /CNW/ - CI Investments Inc. ("CI") announced today that it has become Canada's Number 1 provider of liquid alternative investment solutions and the first to exceed $2 billion in assets under management in this new and rapidly growing market.

CI achieved this impressive milestone in less than 20 months, having launched CI Liquid Alternativestm ("CI liquid alts"), a family of three distinct and innovative mandates, in the fourth quarter of 2018. The lineup recently expanded with the introduction of CI Marret Alternative Enhanced Yield Fund, a new mutual fund and exchange-traded fund ("ETF"), in May 2020.

"CI's liquid alternatives incorporate investment strategies that in the past have typically been available only to institutional investors," said Roy Ratnavel, Executive Vice-President and Head of Distribution for CI. "Our mandates have performed well in the recent challenging market conditions, and our success points to the strength of our liquid alt strategies and their portfolio management teams."

Liquid alternative funds offer investors the potential for enhanced diversification, enhanced returns and reduced volatility, as they allow for access to strategies beyond those typically used by traditional mutual funds and ETFs. CI's flagship liquid alternative mandates have all generated positive returns since inception, and CI Munro Alternative Global Growth has delivered a remarkable 24.2% return over the last 12 months (Source: Morningstar as at June 30, 2020).

"Since launching CI liquid alts in 2018, we have continued to expand the lineup by introducing ETF versions of each mandate earlier this year in addition to the CI Marret Alternative Enhanced Yield strategy in May," Mr. Ratnavel said. "Our commitment to the platform aligns with CI's strategic priority to modernize our asset management business by delivering investment solutions that can help Canadian investors deal with uncertain markets."

The CI Liquid Alternatives lineup includes:

Reporting by the Canadian Association of Alternative Strategies and Assets ("CAASA"), an advocacy group representing both alternative asset managers and investors, shows that CI has the highest level of assets under management for liquid alternative products among 38 self-reporting firms, with just over $2.0 billion as at June 30, 2020.

CI Liquid Alternatives are based on the Canadian Securities Administrators' "alternative mutual funds" rules under National Instrument 81-102 Investment Funds. For more information about CI Liquid Alternatives, visit the liquid alts page of ci.com.

Class F returns in %







CI Munro Alternative Global Growth Fund







CI Marret Alternative Absolute Return Bond Fund







CI Lawrence Park Alternative Investment Grade Credit







Source: Morningstar Direct as at June 30, 2020. Inception date is November 7, 2018.

About CI Investments
CI Investments is one of Canada's largest investment management companies. It offers a wide range of investment products and services and is on the Web at www.ci.com. CI is a subsidiary of CI Financial Corp. (TSX: CIX), an independent company offering global asset management and wealth management advisory services with approximately $179.2 billion in fee-earning assets as at June 30, 2020.

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. The indicated rates of return are the historical annual compounded total returns net of fees and expenses payable by the fund (except for figures of one year or less, which are simple total returns), including changes in security value and reinvestment of all dividends/distributions, and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.

®2020 Morningstar is a registered trademark of Morningstar Research Inc.  All rights reserved.

©2020 Morningstar Research Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

CI Investments and the CI Investments design are registered trademarks of CI Investments Inc. CI Liquid Alternatives is a trademark of CI Investments Inc.

©CI Investments Inc. 2020. All rights reserved.

SOURCE CI Investments Inc.

These press releases may also interest you

at 07:45
Pivot Technology Solutions, Inc. , ("Pivot" or "Company") a full-service information technology solutions provider, today announced that it will report its results for the three and six months ended June 30, 2020 after market close on August 13,...

at 07:45
Biohaven Pharmaceutical Holding Company Ltd. , a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial results for the...

at 07:37
Hycroft Mining Holding Corporation ("Hycroft" or the "Company"), a gold and silver producer operating the Hycroft Mine in the world-class mining region of Northern Nevada, today announced its second quarter operating and financial results for the...

at 07:35
TEGNA Inc. today announced financial results for the second quarter ended June 30, 2020.1 SECOND QUARTER HIGHLIGHTS: Total company revenue was $578 million in the quarter, up eight percent year-over-year. The increase was driven by...

at 07:35
Stoke Therapeutics, Inc. , a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today reported financial results for the second quarter of 2020 and provided...

at 07:35
Sesen Bio , a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported operating results for the second quarter ended June 30, 2020. The Company also provided an update on...

News published on 16 july 2020 at 10:12 and distributed by: